First Light Asset Management, LLC Vaxcyte, Inc. Transaction History
First Light Asset Management, LLC
- $1.28 Billion
- Q1 2024
A detailed history of First Light Asset Management, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, First Light Asset Management, LLC holds 60,284 shares of PCVX stock, worth $4.59 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
60,284Holding current value
$4.59 Million% of portfolio
0.32%Shares
1 transactions
Others Institutions Holding PCVX
# of Institutions
268Shares Held
97.1MCall Options Held
202KPut Options Held
147K-
Vanguard Group Inc Valley Forge, PA9.74MShares$741 Million0.01% of portfolio
-
Black Rock Inc. New York, NY9.51MShares$724 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07.67MShares$584 Million0.29% of portfolio
-
Wellington Management Group LLP Boston, MA4.92MShares$374 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.14MShares$315 Million0.07% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.51B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...